Concepedia

Christopher J. Nirschl

CJ

17

Publications

3.8K

Citations

15

H-Index

2011

Active since

Affiliations

Johns Hopkins University(Current)

Johns Hopkins Medicine

Brigham and Women's Hospital

Harvard University

Sidney Kimmel Comprehensive Cancer Center

Christopher J. Nirschl is an author at Johns Hopkins University specializing in immunology, medicine, and cell biology.

ORCID

Top concepts

Publications per year

2011–2023

17

Publications

17

Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape

Seng‐Ryong Woo, Meghan E. Turnis, Monica V. Goldberg et al. · Cancer Research · 2011 · 1.6K citations · Full text

, , +18

Stereotactic Radiation Therapy Augments Antigen-Specific PD-1–Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen

Andrew B. Sharabi, Christopher J. Nirschl, Christina M. Kochel et al. · Cancer Immunology Research · 2014 · 634 citations · Full text

Oncogenic Kras Activates a Hematopoietic-to-Epithelial IL-17 Signaling Axis in Preinvasive Pancreatic Neoplasia

Florencia McAllister, Jennifer M. Bailey, Janivette Alsina et al. · Cancer Cell · 2014 · 395 citations · Full text

, , +7

IFNγ-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment

Christopher J. Nirschl, Mayte Suárez‐Fariñas, Benjamin Izar et al. · Cell · 2017 · 188 citations · Full text

, , +6

Lymphocyte Activation Gene 3 (LAG-3) Modulates the Ability of CD4 T-cells to Be Suppressed In Vivo

Nicholas M. Durham, Christopher J. Nirschl, Christopher M. Jackson et al. · PLoS ONE · 2014 · 184 citations · Full text

Rows per page

1–5 of 17